These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2114552)

  • 21. Molecular interactions required for triggering alloantigen-specific cytolytic T lymphocytes.
    Kane KP; Sherman LA; Mescher MF
    J Immunol; 1989 Jun; 142(12):4153-60. PubMed ID: 2470815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface contact requirements for activation of cytotoxic T lymphocytes.
    Mescher MF
    J Immunol; 1992 Oct; 149(7):2402-5. PubMed ID: 1527386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 function in thymocyte differentiation and T cell activation.
    Killeen N; Davis CB; Chu K; Crooks ME; Sawada S; Scarborough JD; Boyd KA; Stuart SG; Xu H; Littman DR
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):25-34. PubMed ID: 7904343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.
    Blanchard D; van Els C; Borst J; Carrel S; Boylston A; de Vries JE; Spits H
    J Immunol; 1987 Apr; 138(8):2417-21. PubMed ID: 3104466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement for Q226, but not multiple charged residues, in the class I MHC CD loop/D strand for TCR-activated CD8 accessory function.
    Durairaj M; Sharma R; Varghese JC; Kane KP
    Eur J Immunol; 2003 Mar; 33(3):676-84. PubMed ID: 12616488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class I alloantigen is sufficient for cytolytic T lymphocyte binding and transmembrane signaling.
    Kane KP; Goldstein SA; Mescher MF
    Eur J Immunol; 1988 Dec; 18(12):1925-9. PubMed ID: 3265386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-sized, supported artificial membranes (pseudocytes): response of precursor cytotoxic T lymphocytes to class I MHC proteins.
    Goldstein SA; Mescher MF
    J Immunol; 1986 Dec; 137(11):3383-92. PubMed ID: 3491134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of anti-CD8 resistant cytotoxic T lymphocytes by anti-CD8 antibodies. Functional evidence for T cell signaling induced by multi-valent cross-linking of CD8 on precursor cells.
    McCarthy SA; Kaldjian E; Singer A
    J Immunol; 1988 Dec; 141(11):3737-46. PubMed ID: 2972777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of CD4-CD8+ cytotoxic T cells requires interactions with class I MHC determinants.
    Maruŝić-Galesić S; Stephany DA; Longo DL; Kruisbeek AM
    Nature; 1988 May; 333(6169):180-3. PubMed ID: 3259290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell recognition of nonpolymorphic determinants on H-2 class I molecules.
    Goldstein SA; Mescher MF
    J Immunol; 1988 Jun; 140(11):3707-11. PubMed ID: 2453553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells.
    Acres RB; Conlon PJ; Mochizuki DY; Gallis B
    J Immunol; 1987 Oct; 139(7):2268-74. PubMed ID: 3116077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T lymphocytes against a soluble protein.
    Staerz UD; Karasuyama H; Garner AM
    Nature; 1987 Oct 1-7; 329(6138):449-51. PubMed ID: 2443853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-cell adhesion mediated by CD8 and MHC class I molecules.
    Norment AM; Salter RD; Parham P; Engelhard VH; Littman DR
    Nature; 1988 Nov; 336(6194):79-81. PubMed ID: 3263576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
    Rivas A; Koide J; Laus R; Engleman EG
    J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equilibrium binding of cytotoxic T lymphocytes to class I antigen.
    Mescher MF; O'Rourke AM; Champoux P; Kane KP
    J Immunol; 1991 Jul; 147(1):36-41. PubMed ID: 2051026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.